Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate Brentuximab Biodistribution in CD30-positive Lymphoma

NCT06186986 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06186986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate Brentuximab Biodistribution in CD30-positive Lymphoma
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2024
Completion date
January 31, 2026
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell-lymphoma